Skip to main content

A first biomarker for Parkinson’s disease?

Researchers suggest a blood test to establish the disease stage and help in the choice of treatment

By Jean Hamann – Le Fil de l’Université Laval

A team from the Faculty of Medicine and the Research Center of the CHU de Québec – Université Laval has deposited two patent applications in the USA for a method that would permit to determine the stage of Parkinson’s disease through a blood test.  This method would permit a quick and objective measure of the disease progression, and consequently, would facilitate the choice of the most appropriate treatment for each patient.  This test could help test the efficacy of new treatments for this disease.  These patent applications were signed by professors Francesca Cicchetti, Éric Boilard and Steve Lacroix and the post-doctoral trainee Isabelle St-Amour.

Read more about this story in Le Fil (in French)